Entity Details

Primary name CMC2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9UJS0
EntryNameCMC2_HUMAN
FullNameCalcium-binding mitochondrial carrier protein Aralar2
TaxID9606
Evidenceevidence at protein level
Length675
SequenceStatuscomplete
DateCreated2001-02-21
DateModified2021-06-02

Ontological Relatives

GenesSLC25A13

GO terms

Show/Hide Table
GOName
GO:0005313 L-glutamate transmembrane transporter activity
GO:0005509 calcium ion binding
GO:0005739 mitochondrion
GO:0005743 mitochondrial inner membrane
GO:0005887 integral component of plasma membrane
GO:0006094 gluconeogenesis
GO:0006754 ATP biosynthetic process
GO:0006839 mitochondrial transport
GO:0009066 aspartate family amino acid metabolic process
GO:0015183 L-aspartate transmembrane transporter activity
GO:0015810 aspartate transmembrane transport
GO:0015813 L-glutamate transmembrane transport
GO:0022857 transmembrane transporter activity
GO:0042802 identical protein binding
GO:0043490 malate-aspartate shuttle
GO:0045333 cellular respiration
GO:0051592 response to calcium ion

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion inner membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR002048 EF-hand domainDomainDomain
IPR002067 Mitochondrial carrier proteinFamilyFamily
IPR011992 EF-hand domain pairFamilyHomologous superfamily
IPR018108 Mitochondrial substrate/solute carrierRepeatRepeat
IPR023395 Mitochondrial carrier domain superfamilyFamilyHomologous superfamily
IPR029658 Calcium-binding mitochondrial carrier protein Aralar2FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
605814 OMIMCholestasis, neonatal intrahepatic, caused by citrin deficiency (NICCD)A form of citrullinemia type 2 with neonatal onset, characterized by suppression of the bile flow, hepatic fibrosis, low birth weight, growth retardation, hypoproteinemia, variable liver dysfunction. Neonatal intrahepatic cholestasis due to citrin deficiency is generally not severe and symptoms disappear by one year of age with an appropriate diet. Years or even decades later, however, some individuals develop the characteristic features of citrullinemia type 2 with neuropsychiatric symptoms. The disease is caused by variants affecting the gene represented in this entry.
603471 OMIMCitrullinemia 2 (CTLN2)A form of citrullinemia, an autosomal recessive disease characterized primarily by elevated serum and urine citrulline levels. Ammonia intoxication is another manifestation. Citrullinemia type 2 is characterized by neuropsychiatric symptoms including abnormal behaviors, loss of memory, seizures and coma. Death can result from brain edema. Onset is sudden and usually between the ages of 20 and 50 years. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00128 Aspartic acidDrugbanksmall molecule

Interactions

3 interactions